UPPER NYACK, N.Y.--(BUSINESS WIRE)--Nov 2, 2023--ESI and CVS Health continue to expose hundreds of thousands of patients to the risks of taking medicines their doctor did not prescribe, according to an existing peer-reviewed and updated study, and new research by the Global Healthy Living ...
BOSTON--(BUSINESS WIRE)--Nov 2, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 2, 2023--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the UBS Biopharma Conference on Thursday, Nov. 9, 2023 at 9:00 a.m. ...
AUSTIN, Texas--(BUSINESS WIRE)--Nov 2, 2023--<a ...
BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 2, 2023--Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments. The expanded ...
BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Nov 2, 2023--<a ...